These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 377735)

  • 1. Prolonged survival times of allogeneic skin grafts using somatic cell hybrids.
    Nishihira T; Tan M; Ishii H; Kasai M; Tachibana T
    Transplant Proc; 1979 Mar; 11(1):989-92. PubMed ID: 377735
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective suppression of humoral and cell-mediated immune responses to rat alloantigens by monoclonal antibodies produced by hybridoma cell lines.
    McKearn TJ; Weiss A; Stuart FP; Fitch FW
    Transplant Proc; 1979 Mar; 11(1):932-5. PubMed ID: 377725
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of monoclonal anti-H-2Ld and anti-H-2Dd alloantibodies in the immunological enhancement of skin grafts and neonatal heart grafts in the mouse.
    Lems SP; Jacobs CW; Capel PJ; Koene RA
    J Immunol; 1987 Apr; 138(7):2082-7. PubMed ID: 3549896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of intrathymic mixed chimerism for maintenance of skin allograft tolerance across fully allogeneic (entire major H-2 plus multiminor histocompatibility) antigen barriers in mice.
    Eto M; Nishimura Y; Kong YY; Maeda T; Nomoto K; Kumazawa J; Nomoto K
    Transplant Proc; 1994 Apr; 26(2):841-4. PubMed ID: 8171683
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolongation of skin allograft survival by combined feeding of donor spleen cells and cyclosporine in mice.
    Lu X; Zhou L; Chen S
    Transplant Proc; 2004 Oct; 36(8):2429-31. PubMed ID: 15561269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged allogeneic and xenogeneic microchimerism in unmatched primates without immunosuppression by intrathymic implantation of CD34+ donor marrow cells.
    Allen MD; Weyhrich J; Gaur L; Akimoto H; Hall J; Dalesandro J; Sai S; Thomas R; Nelson KA; Andrews RG
    Cell Immunol; 1997 Nov; 181(2):127-38. PubMed ID: 9398400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
    de Waal RM; Capel PJ; Koene RA
    J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of alloantibody effect on skin graft survival in mice.
    Dohi K; Asahara T; Ono E; Yahata H; Fukuda Y
    Hiroshima J Med Sci; 1984 Jun; 33(2):271-4. PubMed ID: 6384147
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells.
    Roelen DL; Schuurhuis DH; van den Boogaardt DE; Koekkoek K; van Miert PP; van Schip JJ; Laban S; Rea D; Melief CJ; Offringa R; Ossendorp F; Claas FH
    Transplantation; 2003 Dec; 76(11):1608-15. PubMed ID: 14702533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
    Chen BG; Liu Z; Wu Y
    Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
    Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
    J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of GK1.5 and chimeric rat/mouse GK1.5 anti-CD4 antibodies for prolongation of skin allograft survival and suppression of alloantibody production in mice.
    Rashid A; Auchincloss H; Sharon J
    J Immunol; 1992 Mar; 148(5):1382-8. PubMed ID: 1538121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of immunosuppressive effect of anti-recipient alloantiserum. I. Effect on skin graft survival in mice.
    Dohi K; Asahara T; Ono E; Yahata H; Fukuda Y
    Hiroshima J Med Sci; 1984 Sep; 33(3):507-11. PubMed ID: 6392214
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice.
    Bashuda H; Seino K; Kano M; Sato K; Azuma M; Yagita H; Okumura K
    Transplant Proc; 1996 Apr; 28(2):1039-41. PubMed ID: 8623220
    [No Abstract]   [Full Text] [Related]  

  • 16. Tolerance induction of allo-class I H-2 antigen-reactive Lyt-2+ helper T cells and prolonged survival of the corresponding class I H-2-disparate skin graft.
    Azuma T; Sato S; Kitagawa S; Hori S; Kokudo S; Hamaoka T; Fujiwara H
    J Immunol; 1989 Jul; 143(1):1-8. PubMed ID: 2525143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic control of permanently accepted allografts.
    Adelmann A; Sherburne C; Condie RM; Click RE
    Transplant Proc; 1987 Feb; 19(1 Pt 1):890-3. PubMed ID: 3547845
    [No Abstract]   [Full Text] [Related]  

  • 18. Recruitment of effector T lymphocytes by initiator T lymphocytes: application for specific immunosuppression.
    Cohen IR; Belldegrün A; Ben-Nun A; Hazan R
    Transplant Proc; 1981 Mar; 13(1 Pt 1):623-5. PubMed ID: 7022903
    [No Abstract]   [Full Text] [Related]  

  • 19. Improved large burn therapy with reduced mortality following an associated septic challenge by early excision and skin allografting using donor-specific tolerance.
    Garrison JL; Thomas F; Cunningham P
    Transplant Proc; 1995 Feb; 27(1):1416-8. PubMed ID: 7878931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful transfer of donor-specific transplantation tolerance by adoptive transfer of fully allogeneic chimeric bone marrow.
    Wren SM; Hronakes ML; Ildstad ST
    Transplant Proc; 1991 Feb; 23(1 Pt 1):735-6. PubMed ID: 1990670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.